MRVI: Maravai LifeSciences Corp P/S multiplikatori

Maravai LifeSciences Holdings (MRVI) tovar belgisi

Maravai LifeSciences (MRVI) bioanaliz portfelini kengaytirish orqali mRNA mahsulotlariga bo'lgan bog'liqligini kamaytirmoqda, bu o'zgarish P/S koeffitsiyenti dinamikasida aks etgan. GURU.Markets saytidagi ushbu grafikda 5.30 darajasi joriy qiymatni aks ettiruvchi ma'lumotlarni taqdim etadi. Avtomatlashtirilgan CleanCap liniyalari marjaning o'sishini ta'minlamoqda, ekologik toza erituvchilarning joriy etilishi esa "yashil kimyo" tamoyillariga muvofiq ishlab chiqarish toksikligini minimallashtiradi.

MRVI: Maravai LifeSciences P/S multiplikatori 04.07.2022 - 16.11.2026

Maravai (MRVI) kompaniyasining tahliliy kesimlari

Kompaniyaning umumiy tahlili:MRVI, Maravai LifeSciences Corp
Maravai LifeSciences Corp tovar namunasi

Maravai LifeSciences kompaniyasining mRNA terapiyasi uchun yuqori marjali komponentlarning asosiy yetkazib beruvchisi sifatidagi maqomi tushum koeffitsientini biznesning o'sish sur'atlariga bo'lgan bozor ishonchining belgilovchi koeffitsientiga aylantiradi. Ushbu grafik narxning savdoga nisbati koeffitsientini statistik chetlanish prizmasi orqali aks ettiradi, bunda ikki standart chetlanishdan tashqariga chiqish potensial past baholanganlikni yoki narxning chuqur korreksiyasi xavfini signalizatsiya qiladi.

Maravai LifeSciences kimlar bilan raqobatlashadi

Narxning daromadga nisbati A (Agilent)|P/S multiplikatori DGX (questdiagnostics.com)|Illumina Platform - Narxning daromadga nisbati|Exact Sciences Inc. - P/S multiplikatori|RVTY: Narxning daromadga nisbati|Bio-Rad (BIO) - Narxning daromadga nisbati|NNNN - Narx/daromad koeffitsiyenti|SHC (Sotera Health Corp) - P/S multiplikatori|Sotuvga nisbatan narx QuidelOrtho Inc. QDEL|P/S multiplikatori OPK|CareDx - Kapitalizatsiya va daromad nisbati|Fulgent Genetics, Inc. - Kapitalizatsiyaning daromadga nisbati|LAB: Kapitalizatsiya va daromad nisbati|Cytek Corp - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati OSUR (OraSure Technologies)|XGN: P/S multiplikatori|MDxHealth - Bozor kapitallashuvining daromadga nisbati|LUCD (luciddx.com) - P/S multiplikatori|PRE - Narx/daromad multiplikatori|Narxning daromadga nisbati Insight Molecular Diagnostics Inc (IMDX)|TRIB - Sotuvga nisbatan narx|P/S multiplikatori PRPH (ProPhase Labs, Inc.)|Narx/daromad koeffitsiyenti ainos.com (AIMD)|Co-Diagnostics Inc - P/S multiplikatori|HSCS - P/S multiplikatori|BMRA (Biomerica Inc) - Kapitalizatsiyaning daromadga nisbati|CDIO - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Onconetix Inc|VRAX - Narx/daromad multiplikatori|Kapitalizatsiyaning daromadga nisbati BJDX (Bluejay Diagnostics)|P/S multiplikatori Aspira Women's Health, Inc. (AWH)|Narxning daromadga nisbati acceleratediagnostics.com AXDX|Kapitalizatsiyaning sotish hajmiga nisbati CNTG (centogene.com)|ENZ - Narxning daromadga nisbati|FRES - P/S multiplikatori|GENE: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati 23andMe|PMD (Psychemedics Corp.) - P/S multiplikatori